Latest Report Available at Orbis research Tardive Dyskinesia Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Request sample copy of this report at Tardive Dyskinesia Market Research Report 2016
Tardive dyskinesia is an involuntary movement disorder that typically arises from the long-term use of antipsychotic medication in schizoaffective disorders. Tardive dyskinesia is characterized by involuntary, repetitive movements of the face, trunk, or extremities, including lip smacking, grimacing, tongue protrusion, facial movements or blinking, puckering and pursing of the lips. TDs are most common in patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have been treated with antipsychotic medication for long periods, but they occasionally occur in other patients as well.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
The report “Tardive Dyskinesia Market” provides a comprehensive study of the US and Japan tardive dyskinesia market with detailed analysis of market size, growth and penetration of the industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises few large players such as Valeant Pharmaceuticals, Neurocrine Biosciences and Teva Pharmaceuticals Industries Ltd. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/tardive-dyskinesia-market-report-focus-on-us-and-japan-2016-2025 .
Some points from TOC:
- Tardive Dyskinesias – An Overview
1.1 Antipsychotics Overview
1.2 Tardive Dyskinesias
1.3 Signs and Symptoms
1.6 Existing and Pipeline Drugs
- The US Tardive Dyskinesia Market Analysis
2.1 The US Tardive Dyskinesia Market by Number of Patients
2.2 The US Tardive Dyskinesia – Number of Patients by Severity
2.3 The US Tardive Dyskinesia Sales by Value
2.4 The US Tardive Dyskinesia Annual Price
Purchase a copy of Tardive Dyskinesia Market visit @ http://www.orbisresearch.com/contact/purchase/329839 For more information contact email@example.com .
- Japan Tardive Dyskinesia Market Analysis
3.1 Japan Tardive Dyskinesia Market by Number of Patients
3.2 Japan Tardive Dyskinesia – Number of Patients by Severity
3.3 Japan Tardive Dyskinesia Sales by Value
3.4 Japan Tardive Dyskinesia Annual Price
- The US Tardive Dyskinesia Drugs Market Analysis
4.1 The US Valbenazine Market by Penetration
4.2 The US SD-809 Market by Penetration
4.3 The US Tetrabenazine Market For Tardive Dyskinesia by Penetration
- Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Schizophrenia Patients
5.1.2 Increasing Bipolar Patients
5.1.3 Growing Antipsychotic Prescription
5.1.4 Increased Use of Long-Term Neuroleptic Drugs
5.1.5 Increasing Incidence of Neurological Disorders
5.2 Market Trends
5.2.1 Medications Causing Tardive Dyskinesia
5.3.1 Side Effects of Drugs
- Competitive Landscape
6.1 Comparison between Valbenazine vs. SD-809
- Company Profiles
7.1 Valeant Pharmaceuticals
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Neurocrine Biosciences
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Teva Pharmaceuticals Industries Ltd.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research